Gary W. Pace made two open market purchases of Cardiff Oncology ($CRDF) shares in the last year, totaling $710,500. His latest buy occurred on July 30, 2025. Ranking 679th among nearly 5,000 insiders for purchase volume, his activity falls below the average of 1.5 million dollars and 3.3 transactions per buyer. He reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 30, 2025 | Cardiff Oncology, Inc. | $CRDF | PACE GARY W | Not found | P | Common Stock | 275000 | $2.45 | 2,676,352.0000 | 66,524,294 | 11.45% | 0.41% |
| July 30, 2025 | Cardiff Oncology, Inc. | $CRDF | PACE GARY W | Not found | P | Common Stock | 15000 | $2.45 | 2,676,352.0000 | 66,524,294 | 0.56% | 0.02% |
| June 26, 2025 | Cardiff Oncology, Inc. | $CRDF | PACE GARY W | Director | A | Stock Options | 40565 | $0.00 | 187,539.0000 | 66,524,294 | 27.60% | 0.06% |
| Dec. 11, 2024 | Cardiff Oncology, Inc. | $CRDF | PACE GARY W | Not found | P | Common Stock | 350115 | $2.60 | 2,107,252.0000 | 0 | 19.93% | 0.00% |
| Dec. 11, 2024 | Cardiff Oncology, Inc. | $CRDF | PACE GARY W | Not found | P | Common Stock | 11500 | $2.60 | 2,107,252.0000 | 0 | 0.55% | 0.00% |
| June 27, 2024 | Cardiff Oncology, Inc. | $CRDF | PACE GARY W | Director | A | Stock Options | 29700 | $0.00 | 146,974.0000 | 0 | 25.33% | 0.00% |
| March 6, 2024 | Pacira BioSciences, Inc. | $PCRX | PACE GARY W | Director | S | Common Stock | 1066 | $29.67 | 140,384.0000 | 51,979,000 | 0.75% | 0.00% |
| March 7, 2024 | Pacira BioSciences, Inc. | $PCRX | PACE GARY W | Director | S | Common Stock | 28257 | $30.81 | 112,127.0000 | 51,979,000 | 20.13% | 0.05% |
| March 8, 2024 | Pacira BioSciences, Inc. | $PCRX | PACE GARY W | Director | S | Common Stock | 90000 | $30.60 | 22,127.0000 | 51,979,000 | 80.27% | 0.17% |
| Dec. 19, 2023 | Cardiff Oncology, Inc. | $CRDF | PACE GARY W | Director | P | Common Stock | 30000 | $1.37 | 697,761.0000 | 0 | 4.49% | 0.00% |
| Nov. 10, 2023 | Cardiff Oncology, Inc. | $CRDF | PACE GARY W | Director | P | Common Stock | 22950 | $0.98 | 667,761.0000 | 0 | 3.56% | 0.00% |
| June 15, 2023 | Cardiff Oncology, Inc. | $CRDF | PACE GARY W | Director | A | Stock Options | 27700 | $0.00 | 117,274.0000 | 0 | 30.92% | 0.00% |
| June 14, 2023 | Pacira BioSciences, Inc. | $PCRX | PACE GARY W | Director | A | Common Stock | 1775 | $0.00 | 141,450.0000 | 46,538,000 | 1.27% | 0.00% |
| June 14, 2023 | Pacira BioSciences, Inc. | $PCRX | PACE GARY W | Director | A | Stock Option (Right to Buy) | 12925 | $0.00 | 12,925.0000 | 46,538,000 | 9999.99% | 0.03% |
| May 11, 2023 | Pacira BioSciences, Inc. | $PCRX | PACE GARY W | Director | M | Common Stock | 7000 | $29.90 | 144,690.0000 | 46,538,000 | 5.08% | 0.02% |
| May 11, 2023 | Pacira BioSciences, Inc. | $PCRX | PACE GARY W | Director | S | Common Stock | 5015 | $41.78 | 139,675.0000 | 46,538,000 | 3.47% | 0.01% |
| May 11, 2023 | Pacira BioSciences, Inc. | $PCRX | PACE GARY W | Director | M | Stock Option (Right to Buy) | 7000 | $0.00 | 0.0000 | 46,538,000 | 100.00% | 0.02% |